POU5F1 and glioblastoma: Indeed, downregulation of CD133 did not sensitise glioblastoma cells to temozolomide [14] but OCT4 expression is associated with tumour malignancy in astrocytic brain tumours [41] and indicates negative prognosis in Cervical Squamous Cell Carcinoma [42].